Never miss a memo!
Contract Year 2024 Monitoring of Posted Comprehensive Formularies
Relevant to: MAOs, PDPs, Cost
Read MoreAttestation of Prescription Drug Event (PDE) Data and Direct and Indirect Remuneration (DIR) Data related to the 2018 Reopening
Relevant to: All Part D Plan Sponsors, PACE
Read MoreContract Year (CY) 2024 Online Enrollment Center (OEC) Special Enrollment Period (SEP) Code Updates
Relevant to: Cost, MA, PDPs, RFB, SNP
Read MoreCorrections to the Year of Service (YOS) 2021 Polypharmacy: Use of Multiple Central-Nervous System – Active Medications in Older
Relevant to: PDPs, PACE, Cost, MA-PD
Read MoreMedicare Advantage/Prescription Drug System (MARx) October 2023 Payment – INFORMATION
Relevant to: PDPs, MAOs, PACE, Cost
Read MoreNon-Renewal and Service Area Reduction Guidance and EnrolleeNotification Models
Relevant to: MAOs, PDPs, Cost, MMPs
Read MoreResults of the 2023 Part C and D Reporting Requirements Data Validation
Relevant to: MMPs, PDPs, MAOs
Read MoreContract Year 2024 Annual Notice of Change and Evidence of Coverage Submission Requirements and Yearly Assessment
Relevant to: MAOs, MMPs, PDPs, MA-PDOs, Cost
Read MoreMedicare Advantage/Prescription Drug System (MARx) September 2023 Payment – INFORMATION
Relevant to: MAOs, PDPs, Cost, PACE
Read MoreContract Year (CY) 2024 Online Enrollment Center (OEC) Timeline and Requirements
Relevant to: MA, PDPs, RFB, SNP, Cost
Read MoreCY 2024 September Formulary Enhancement Submission Window
Relevant to: PDPs, MA-PDPs, Cost, MMPs, PACE
Read MoreInformation for the Second Contract Year (CY) 2024 Drug Pricing and Plan Benefit Previews
Relevant to: Cost, MA, PDPs
Read More